Pediatrics Articles

Pediatrics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kuehn BM – The scientists identified 9 children from 6 families who were homozygous for mutations in IL1RN, a gene in the interleukin 1 (IL–1) pathway, and who developed severe skin and bone inflammation shortly after birth. The protein product of IL1RN inhibits IL–1, and unchecked IL–1 causes life–threatening inflammation in these patients. Five of 6 surviving patients treated with anakinra, a recombinant IL–1–receptor antagonist, experienced remission; the patient who did not respond to the drug had chromosomal deletions that included IL1RN.

Related Articles

New Insights into Whipple's Disease - A Rare Intestinal Inflammatory Disorder
Digestive Diseases, 11/09/09    Relevance Score: 79%

Intravenous iron in inflammatory bowel disease
World Journal of Gastroenterology, 10/14/09    Relevance Score: 79%

New drugs for migraine
The Journal of Headache and Pain, 10/05/09    Relevance Score: 79%

Diagnostic and Treatment Algorithms of Ulcerative Colitis in Ukraine
Digestive Diseases, 11/09/09    Relevance Score: 78%

Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Gastroenterology, 10/28/09    Relevance Score: 78%

Today in Peds Allergy/Immunology...keeping you current

Persistent antibody depletion after rituximab in three children with autoimmune cytopenias
Pediatric Hematology and Oncology, 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans
Journal of Allergy and Clinical Immunology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address